Hemophilia: role of organ homografts

Science
T L MarchioroE D Thomas

Abstract

The concentration of factor VIII and partial thromboplastin times became normal and have remained normal for 140 days after orthotopic tranplantation of a normal liver to a hemophilic dog. Transplantation of a normal spleen into a hemophilic recipient did not result in a significant increase in factor VIII although the splenic graft was viable for at least 47 days. Transplantation of normal marrow to a lethally irradiated hemophilic dog did not result in an increase in factor VIII during 34 days of observation.

References

Jan 1, 1968·Transplantation·R B EpsteinE D Thomas
Jan 1, 1959·British Journal of Haematology·J G POOL, J ROBINSON
Feb 1, 1964·The American Journal of Physiology·R A WEAVERR D LANGDELL
Aug 11, 1960·The New England Journal of Medicine·S I RAPAPORTJ R GOODMAN

❮ Previous
Next ❯

Citations

May 1, 1995·Journal of Hepatology·J P LerutJ B Otte
Jan 1, 1993·Biotechnology Advances·F ManningR O'Kennedy
May 2, 1985·The New England Journal of Medicine·J H LewisT E Starzl
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·K ZatloukalM L Birnstiel
Sep 1, 1975·British Journal of Haematology·E J BowieC A Owen
May 24, 1969·British Medical Journal
May 6, 1972·British Medical Journal·D N Raine
Jun 1, 1973·The Journal of Clinical Investigation·F R RicklesM E Conrad
Nov 1, 1973·The Journal of Clinical Investigation·L W HoyerJ R Hoyer
Dec 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Anna AronovichYair Reisner
Feb 1, 1990·American Journal of Hematology·M A DelormeW J Wall
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·G I Ingram
Aug 1, 1973·CRC Critical Reviews in Biochemistry·E Triantaphyllopoulos, D C Triantaphyllopoulos
Jan 16, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·K ØvlisenM Tranholm
Feb 6, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·L MartorellF Vidal
Oct 15, 2013·Journal of Thrombosis and Haemostasis : JTH·T ShahaniM Jacquemin
Oct 1, 1970·Journal of Chronic Diseases·D Green
Aug 1, 1992·Thrombosis Research·K M Brinkhous
Apr 1, 1984·British Journal of Haematology·D A KellyE G Tuddenham
Oct 1, 1980·British Journal of Haematology·R T WallG E Striker
Apr 11, 2014·Blood·Lesley A EverettDavid Ginsburg
Mar 1, 2012·Blood·Antonia FollenziSanjeev Gupta
Jul 3, 1999·The Journal of Biological Chemistry·H DoP Lollar
Jan 31, 2020·Journal of Thrombosis and Haemostasis : JTH·Christine J KurianSanaa Rizk
Mar 30, 2006·Blood·Marc JacqueminCharles James Kirkpatrick
Dec 1, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·A A AshraniN S Key
Jul 23, 2021·Scientific Reports·Morisada HayakawaTsukasa Ohmori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.